Amplification of Regulatory T Cells Using a CD28 Superagonist Reduces Brain Damage After Ischemic Stroke in Mice
Stroke2014Vol. 46(1), pp. 212–220
Citations Over TimeTop 10% of 2014 papers
Abstract
In vivo expansion and amplification of Treg by CD28SA attenuates the inflammatory response and improves outcome after experimental stroke.
Related Papers
- → Absence of B7-dependent responses in CD28-deficient mice(1994)377 cited
- → Role of IL-12 and 4-1BB ligand in cytokine production by CD28+ and CD28- T cells(1997)76 cited
- → Synergy between CD28 and CD9 costimulation for naive T-cell activation(1997)14 cited
- → CD28 delivers costimulatory signals independently of its association with phosphatidylinositol 3-kinase(1995)62 cited
- → Generation of CD28− cells from long-term-stimulated CD8+CD28+ T cells: a possible mechanism accounting for the increased number of CD8+CD28− T cells in HIV-1-infected patients(1999)25 cited